Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis

Journal of Immunology

Volumn 193, Issue 2, 2014, Pages 564-570

  Stoolman, Joshua S ^a   Duncker, Patrick C ^a   Huber, Amanda K ^a   Segal, Benjamin M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; CXCL2 CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BRAIN STEM; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CHEMOKINES; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; IMMUNOPHENOTYPING; INFLAMMATION; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MONOCYTES; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUTROPHILS; PEPTIDE FRAGMENTS; RECEPTORS, CCR2; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN-8B;

EID: 84904268878     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400825     Document Type: Article

References (31)

1. Polman, C. H., S. C. Reingold, B. Banwell, M. Clanet, J. A. Cohen, M. Filippi, K. Fujihara, E. Havrdova, M. Hutchinson, L. Kappos, et al. 2011. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69: 292-302.
2. Ishizu, T., M. Osoegawa, F. J. Mei, H. Kikuchi, M. Tanaka, Y. Takakura, M. Minohara, H. Murai, F. Mihara, T. Taniwaki, and J. Kira. 2005. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128: 988-1002. (Pubitemid 40675455)
3. Rovaris, M., M. Bozzali, G. Santuccio, A. Ghezzi, D. Caputo, E. Montanari, A. Bertolotto, R. Bergamaschi, R. Capra, G. Mancardi, et al. 2001. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124: 2540-2549. (Pubitemid 33134941)
4. Stevenson, V. L., S. M. Leary, N. A. Losseff, G. J. Parker, G. J. Barker, Y. Husmani, D. H. Miller, and A. J. Thompson. 1998. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51: 234-238. (Pubitemid 28345389)
5. Rovaris, M., E. Judica, A. Ceccarelli, A. Ghezzi, V. Martinelli, G. Comi, and M. Filippi. 2008. Absence of diffuse cervical cord tissue damage in early, nondisabling relapsing-remitting MS: a preliminary study. Mult. Scler. 14: 853-856.
6. Lin, X., L. D. Blumhardt, and C. S. Constantinescu. 2003. The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study. Acta Neurol. Scand. 108: 401-406. (Pubitemid 37464119)
7. Raine, C. S., L. B. Barnett, A. Brown, T. Behar, and D. E. McFarlin. 1980. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43: 150-157. (Pubitemid 10043144)
8. Muller, D. M., M. P. Pender, and J. M. Greer. 2005. Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement. J. Neuroimmunol. 160: 162-169. (Pubitemid 40248605)
9. Abromson-Leeman, S., R. Bronson, Y. Luo, M. Berman, R. Leeman, J. Leeman, and M. Dorf. 2004. T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis. Am. J. Pathol. 165: 1519-1533. (Pubitemid 39435152)
10. Lee, E., S. Chanamara, D. Pleasure, and A. M. Soulika. 2012. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J. Neuroinflammation 9: 7.
11. Stromnes, I. M., L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14: 337-342. (Pubitemid 351347910)
12. Lees, J. R., P. T. Golumbek, J. Sim, D. Dorsey, and J. H. Russell. 2008. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205: 2633-2642.
13. Wensky, A. K., G. C. Furtado, M. C. Marcondes, S. Chen, D. Manfra, S. A. Lira, D. Zagzag, and J. J. Lafaille. 2005. IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis. J. Immunol. 174: 1416-1423.
14. Kroenke, M. A., S. W. Chensue, and B. M. Segal. 2010. EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur. J. Immunol. 40: 2340-2348.
15. Iwakura, Y., H. Ishigame, S. Saijo, and S. Nakae. 2011. Functional specialization of interleukin-17 family members. Immunity 34: 149-162.
16. de Bruin, A. M., S. F. Libregts, M. Valkhof, L. Boon, I. P. Touw, and M. A. Nolte. 2012. IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood 119: 1543-1554.
17. Mehrad, B., R. M. Strieter, T.A. Moore,W. C. Tsai, S. A. Lira, and T. J. Standiford. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophilmediated host defense in invasive pulmonary aspergillosis. J. Immunol. 163: 6086-6094.
18. Hosking, M. P., L. Liu, R. M. Ransohoff, and T. E. Lane. 2009. A protective role for ELR+ chemokines during acute viral encephalomyelitis. PLoS Pathog. 5: e1000648.
19. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541. (Pubitemid 351962016)
20. Muller, D. M., M. P. Pender, and J. M. Greer. 2000. A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction. Acta Neuropathol. 100: 174-182. (Pubitemid 30456140)
21. Skundric, D. S., C. Kim, H. Y. Tse, and C. S. Raine. 1993. Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice. J. Neuroimmunol. 46: 113-121.
22. Carlson, T., M. Kroenke, P. Rao, T. E. Lane, and B. Segal. 2008. The Th17-ELR + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205: 811-823. (Pubitemid 351549880)
23. Kawakami, N., S. Lassmann, Z. Li, F. Odoardi, T. Ritter, T. Ziemssen, W. E. Klinkert, J. W. Ellwart, M. Bradl, K. Krivacic, et al. 2004. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199: 185-197. (Pubitemid 38129699)
24. Berger, T., S. Weerth, K. Kojima, C. Linington, H. Wekerle, and H. Lassmann. 1997. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76: 355-364. (Pubitemid 27157343)
25. + NK cells exacerbates Listeria monocytogenes infection in mice by inhibiting granulocyte mobilization. Eur. J. Immunol. 43: 2626-2637.
26. Sadik, C. D., N. D. Kim, and A. D. Luster. 2011. Neutrophils cascading their way to inflammation. Trends Immunol. 32: 452-460.
27. Nygårdas, P. T., J. A. Määttä, and A. E. Hinkkanen. 2000. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse. Eur. J. Immunol. 30: 1911-1918. (Pubitemid 30456187)
28. Glabinski, A. R., M. Tani, R. M. Strieter, V. K. Tuohy, and R. M. Ransohoff. 1997. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150: 617-630. (Pubitemid 27073789)
29. Marques, F., J. C. Sousa, G. Coppola, D. H. Geschwind, N. Sousa, J. A. Palha, and M. Correia-Neves. 2009. The choroid plexus response to a repeated peripheral inflammatory stimulus. BMC Neurosci. 10: 135.
30. Cruz-Orengo, L., D. W. Holman, D. Dorsey, L. Zhou, P. Zhang, M. Wright, E. E. McCandless, J. R. Patel, G. D. Luker, D. R. Littman, et al. 2011. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208: 327-339.
31. Simmons, S. B., D. Liggitt, and J. M. Goverman. 2014. Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis. J. Immunol. 193: 555-563.